ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2021

Higher Genetic Risk Load in Patients with More Diverse Manifestations in a Korean Systemic Lupus Erythematosus Cohort

So-Young Bang1, Eunji Ha 2, Hyuk-Hee Kwon 3, Hyun-Seung Yoo 4, Juyeon Kang 1, Ji-Soong Kim 1, Bora Nam 1, Jung-Min Shin 1, Yeon-Kyung Lee 1, Tae-Han Lee 5, Hye-Soon Lee 6, Kwangwoo Kim 2 and Sang-Cheol Bae 1, 1Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 2Kyung Hee University, Seoul, Republic of Korea, 3Hanyang University Hospital, Guri, 4Hanyang University Hospital, Guri, Republic of Korea, 5Hanyang University, Seoul, 6Department of Internal Medicine, Hanyang University Guri Hospital,Hanyang University School of Medicine, Guri, Korea, Guri, Republic of Korea

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: classification criteria and risk, genetics, phenotypes, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: SLE – Etiology & Pathogenesis Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose:

Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease with diverse heterogeneous phenotypes. Although many studies of SLE presented estimates of high heritability, impact of complex genetic variants on the clinical manifestations and antibodies profiles of SLE was not fully understood. The aim of this study is to identify the genetic load by genetic risk score (GRS) that influence the clinical and serological manifestations according to ACR criteria in patients with SLE.

Methods: A total of 781 Korean patients from the Hanyang BAE lupus cohort were genotyped by genome-wide association study array. Weighted genetic risk score (GRS) were calculated from 45 well-validated non-HLA SNPs and HLA SLE-risk loci. Individual GRS was tested for associations with the clinical subphenotypes based on ACR criteria of SLE and the development of autoantibody by using a multivariable linear regression or a logistic regression.

Results: We identified weighted GRS calculated from non-HLA and HLA SLE-risk loci with significant associations in various SLE subphenotypes defined by the ACR criteria (mean number 5.74) among 11 criteria. Individual’s weighted GRS showed significantly positive correlation with the number of ACR criteria in a linear regression model (β coefficient = 0.13, p = 9.00×10−3). Consistently, a significant positive correlation with the number of ACR in both non-HLA GRS (β = 0.11, p = 0.027) and HLA GRS (β 0.06, p = 0.021) was observed, respectively.

In a clinical subphenotype analysis, weighted GRS from non-HLA and HLA risk loci were significantly related to malar rash (OR 1.23, p = 2.68×10−3), renal disorder (OR 1.15, p = 4.41×10−2), and thrombocytopenia (OR 1.21, p = 7.55×10−3) using a multivariable logistic regression. Weighted GRS were strongly associated with production of anti-DNA antibody (OR 1.38, p = 2.18×10−3).

Conclusion:

In conclusion, genetic risk load of SLE is significantly higher in individuals with more diverse clinical and serological manifestations. Several subphenotypes (malar rash, renal disorder, thrombocytopenia and anti-dsDNA antibody) might be influenced by cumulative genetic risk load.


Disclosure: S. Bang, Hanyang University, 3; E. Ha, None; H. Kwon, None; H. Yoo, None; J. Kang, None; J. Kim, None; B. Nam, None; J. Shin, None; Y. Lee, None; T. Lee, None; H. Lee, None; K. Kim, None; S. Bae, None.

To cite this abstract in AMA style:

Bang S, Ha E, Kwon H, Yoo H, Kang J, Kim J, Nam B, Shin J, Lee Y, Lee T, Lee H, Kim K, Bae S. Higher Genetic Risk Load in Patients with More Diverse Manifestations in a Korean Systemic Lupus Erythematosus Cohort [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/higher-genetic-risk-load-in-patients-with-more-diverse-manifestations-in-a-korean-systemic-lupus-erythematosus-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/higher-genetic-risk-load-in-patients-with-more-diverse-manifestations-in-a-korean-systemic-lupus-erythematosus-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology